Use your antibodies-online credentials, if available.
MARK2 encodes a member of the Par-1 family of serine/threonine protein kinases. 再加上，我们可以发MAP/microtubule Affinity-Regulating Kinase 2 蛋白 (10)和数多这个蛋白质的别的产品。
Showing 10 out of 96 products:
Cow (Bovine) Polyclonal MARK2 Primary Antibody for EIA, WB - ABIN401318
Hurov, Watkins, Piwnica-Worms: Atypical PKC phosphorylates PAR-1 kinases to regulate localization and activity. in Current biology : CB 2004
Show all 6 references for 401318
Human Monoclonal MARK2 Primary Antibody for ELISA, WB - ABIN393666
Yoshimura, Terabayashi, Miki: Par1b/MARK2 phosphorylates kinesin-like motor protein GAKIN/KIF13B to regulate axon formation. in Molecular and cellular biology 2010
Show all 5 references for 393666
Human Polyclonal MARK2 Primary Antibody for IHC (p), WB - ABIN392538
Blume-Jensen, Hunter: Oncogenic kinase signalling. in Nature 2001
Show all 2 references for 392538
Human Polyclonal MARK2 Primary Antibody for ELISA, WB - ABIN314316
Depasquale, Thompson: Prognosis in human melanoma: PAR-1 expression is superior to other coagulation components and VEGF. in Histopathology 2008
Human Monoclonal MARK2 Primary Antibody for ELISA, WB - ABIN560734
Hezel, Gurumurthy, Granot, Swisa, Chu, Bailey, Dor, Bardeesy, Depinho: Pancreatic LKB1 deletion leads to acinar polarity defects and cystic neoplasms. in Molecular and cellular biology 2008
Human Polyclonal MARK2 Primary Antibody for IF, ELISA - ABIN1533969
Taylor, Noguchi, Totoki, Toyoda, Kuroki, Dewar, Lloyd, Itoh, Takeda, Kim, She, Barlow, Bloom, Bruford, Chang, Cuomo, Eichler, FitzGerald, Jaffe, LaButti, Nicol, Park, Seaman, Sougnez, Yang, Zimmer et al.: Human chromosome 11 DNA sequence and analysis including novel gene identification. ... in Nature 2006
Human Polyclonal MARK2 Primary Antibody for EIA, IHC (p) - ABIN360425
Cantrell: Phosphoinositide 3-kinase signalling pathways. in Journal of cell science 2001
In the modeled structure of inactive MARK2, activation segment occludes the enzyme active site and assumes a relatively stable position.
In conclusion, baicalin and DDP (显示 TIMM8A 抗体) were synergistic at inhibiting proliferation and invasion of human lung cancer cells at appropriate dosages and incubation time in the presence or absence of DDP (显示 TIMM8A 抗体) resistance. The attenuation of DDP (显示 TIMM8A 抗体) resistance was associated with downregulation of MARK2 and p-Akt (显示 AKT1 抗体).
MARK2 plays a role in promoting malignant phenotypes of lung cancer.
Phosphorylation of RNF41 (显示 RNF41 抗体) by Par-1b regulates basolateral membrane targeting of laminin-111 receptors.
induces asymmetric inheritance of plasma membrane domains via LGN (显示 GPSM2 抗体)-dependent mitotic spindle orientation in proliferating hepatocytes
Perturbation of PAR1b and SHP2 (显示 PTPN11 抗体) by CagA (显示 S100A8 抗体) underlies the oncogenic potential of CagA (显示 S100A8 抗体).
The MARK2 binds to the N-terminal tail of Tau and selectively phosphorylates three major and five minor serine residues in the repeat domain and C-terminal tail.
Hepatocyte Par1b defines lumen position in concert with the position of the astral microtubule anchoring complex LGN (显示 GPSM2 抗体)-NuMA (显示 NUMA1 抗体) to yield the distinct epithelial division phenotypes.
automated image analysis of MT assembly dynamics identified MARK2 as a target regulated downstream of Rac1 that promotes oriented MT growth in the leading edge to mediate directed cell migration.
The scaffolding adaptor GAB1 (显示 GAB1 抗体) interacts with two polarity proteins, PAR1 and PAR3 (显示 F2RL2 抗体).
data suggest ectopic PAR1 (显示 F2R 抗体) expression is not tolerated in mouse platelets and indicate a different approach is required to develop a small animal model for the purpose of any future preclinical testing of PAR (显示 AFG3L2 抗体) antagonists as anti-platelet drugs
a model whereby MARK2 negatively regulates insulin (显示 INS 抗体) sensitivity in peripheral tissue through inhibition of KSR1 (显示 KSR1 抗体)
ROCK1 (显示 ROCK1 抗体)/PAR-1b-dependent regulation of basement membrane placement is required for the coordination of tissue polarity and the elaboration of tissue structure in the developing submandibular salivary gland.
PAR1b plays a novel role in the maintenance of mature dendritic spine morphology by regulating microtubule growth and the accumulation of p140Cap (显示 SRCIN1 抗体) in dendritic spines.
Par-1b is a regulator of glucose metabolism and adiposity in the whole animal
Interaction of MARK2 with CaMKI (显示 CAMK1 抗体) results in a novel, calcium-dependent pathway that plays an important role in neuronal differentiation.
Akt (显示 AKT1 抗体) enhances the activity of PAR1 (显示 F2R 抗体) to promote tau hyperphosphorylation at S262/S356, a tau species that is not recognized by the CHIP/Hsp90 (显示 HSP90 抗体) complex
Coreduction of MARK2 and DCX (显示 DCX 抗体) resulted in a partial restoration of the normal neuronal migration phenotype in vivo. The kinetic behavior of the centrosomes reflected the different molecular mechanisms activated when either protein was reduced.
This gene encodes a member of the Par-1 family of serine/threonine protein kinases. The protein is an important regulator of cell polarity in epithelial and neuronal cells, and also controls the stability of microtubules through phosphorylation and inactivation of several microtubule-associating proteins. The protein localizes to cell membranes. Multiple transcript variants encoding different isoforms have been found for this gene.
ELKL motif kinase 1
, PAR1 homolog b
, Ser/Thr protein kinase PAR-1B
, serine/threonine protein kinase EMK
, serine/threonine-protein kinase MARK2
, serine/threonine kinase